Estrella Immunopharma, Inc (ESLA)
NCM · Common · CUSIP 297584104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ESLA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Bank Holding Company
CUSIP
297584104
IPO
7/15/2023 · $10.00/unit
Previous Symbol
UPTD (changed 10/2/2023)
Previous Name
TradeUP Acquisition Corp
Business: Estrella Immunopharma, Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Company Contact

CEO
Cheng Liu
CFO
Jiandong (Peter) Xu
Headquarters
5858 Horton Street, Suite 370, Emeryville, CA 95608
Phone
510-318-9098
Email Form
Contact Form »
SEC EDGAR Filings
View filings »